S*BIO PTE LTD
S*Bio Pte Ltd. (Singapore), The principle activity of the company is the discovery and development of novel, proprietary small molecule anti-cancer drugs. This is done through an in-house discovery team located in Singapore and a clinical development team located in Singapore and Calfornia.
S*BIO PTE LTD
Industry:
Biotechnology Genetics Life Science
Founded:
2000-01-01
Address:
Singapore, Central Region, Singapore
Country:
Singapore
Status:
Active
Similar Organizations
BiSiChem
BiSiChem is a biotechnology company that focuses on the drug discovery and development field.
Current Employees Featured
More informations about "S*BIO Pte Ltd"
S*Bio - Crunchbase Company Profile & Funding
S*BIO Pte, Ltd., a biotech company, focuses on the discovery and clinical development of novel targeted small drugs for the treatment of cancer. It serves the biotechnology industry in Singapore. The company was founded in 2000 and is based in Singapore, Singapore. S*BIO …See details»
S*BIO Pte Ltd - Singapur, Singapore - bionity.com
Dec 5, 2022 S*BIO Pte Ltd. 1 Science Park Road; #05-09 The Capricorn; Singapore Science Park II 117 528 Singapur Singapore +6568275000. sbio.com. Profile Products News White papers & webinars. About S*BIO Pte.See details»
S*BIO PTE LTD (200004639G) - Singapore Company
S*BIO PTE LTD. Registration No. / Unique Entity Number: 200004639G issued by Accounting And Corporate Regulatory Authority S*BIO PTE LTD (the "Company") is a Private Company Limited by Shares, incorporated on 26 May 2000 (Friday) in Singapore . The address of the …See details»
S*BIO Pte Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Explore S*BIO Pte Ltd. with its drug pipeline, therapeutic area, technology platform, 12 clinical trials, 2 news, and 10 literature, Drug:Pacritinib, Pracinostat Hydrochloride, SB-639. ... The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted …See details»
S*Bio Pte Ltd - Company Profile and News - Bloomberg Markets
Company profile page for S*Bio Pte Ltd including stock price, company news, executives, board members, and contact informationSee details»
S*BIO Pte Ltd - Drug pipelines, Patents, Clinical trials - Synapse
Explore S*BIO Pte Ltd with its drug pipeline, therapeutic area, technology platform, . Explore S*BIO Pte Ltd with its drug pipeline, therapeutic area, technology platform, . Biomedical products. Data. Feature. Plans. Sign Up for Free. Request Demo. Sign Up for Free. Last update 02 Aug …See details»
S*BIO PTE LTD Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for S*BIO PTE LTD of Singapore. Get the latest business insights from Dun & Bradstreet.See details»
S*BIO Pte Ltd - Crunchbase
S*BIO Pte Ltd., a biotech company, focuses on the discovery, research, and clinical development of small molecule drugs.See details»
S*BIO PTE LTD :: Singapore - OpenCorporates
Free and open company data on Singapore company S*BIO PTE LTD (company number 200004639G), 250 NORTH BRIDGE ROAD, #28-00, RAFFLES CITY TOWER, 179101 Changes to our website — to find out why access to some data now requires a login, click hereSee details»
S*BIO PTE LTD - Profile, contacts and insights - The Grid
Find key decision-makers, contacts, emails, headcount, share capital, recent funding, IPO status and other insights of S*BIO PTE LTD.See details»
S*BIO Pte. Ltd. - BioCentury Company Profiles - BCIQ
Apr 24, 2023 S*BIO Pte. Ltd. - BioCentury Company Profiles for the biopharma industrySee details»
S*BIO Pte Ltd. - Mitsui & Co. Global Investment, Inc.
S*BIO Pte Ltd. S*BIO focuses on the discovery and clinical development of targeted drugs for the treatment of cancer. Website: S*BIO. Location: Singapore. Status: Acquired by Cell Therapeutics. News: Latest news from S*BIO. Investment Team:See details»
S*BIO Pte Ltd Management Team | Org Chart - RocketReach
S*BIO Pte Ltd employs 17 employees. The S*BIO Pte Ltd management team includes Elizabeth Shigezumi (Senior Clinical Trial Manager), Adeline Lum (Head, Finance & Operations), and Kantharaj Ethirajulu (Head, PKDM). Get Contact Info for All Departments S*BIO Pte Ltd Org …See details»
S*Bio, Singapore, SG | Company Information
S*BIO is a privately-held biotech company focused on the research and clinical development of novel targeted small molecule drugs for the treatment of cancer with leading programs around histone d ...See details»
S*bio Pte. Ltd. - Overview, Competitors and Decision Makers from …
S*bio Pte. Ltd.is headquartered in Singapore, Singapore - specialized in Biotechnology - Find employees, decision makers, competitors and company information. DataLead allows to search for B2B contacts and companies by job title, location, keywords, industries, experience, …See details»
S*Bio Pte Ltd - VC DATALAB profile - data.kando.tech
Singapore-based cancer therapeutics company which, focuses on the discovery, research, and clinical development of small molecule drugs.See details»
S*BIO Pte Ltd - Contacts, Employees, Board Members
Organization. S*BIO Pte Ltd . Connect to CRM . Save . Summary. People. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. S*BIO Pte Ltd has 1 current employee profile, Senior Scientist Murugappan Ramanujulu. Contacts. Edit Contacts Section. …See details»
S*BIO becomes Singapore's first biotech company to initiate …
Jun 22, 2007 S*BIO Pte Ltd announced that it has become Singapore's first biotechnology company to initiate a Phase I clinical trial of a novel anti-cancer compound. The compound, SB939, belongs to a new class of targeted anti-cancer therapeutics called histone deacetylase …See details»
S*BIO’s Novel JAK2 Inhibitor Pacritinib (SB1518) Effectively …
Dec 15, 2011 S*BIO Pte Ltd announced that results from a Phase 2 study demonstrated that its JAK2 inhibitor pacritinib (SB1518) effectively reduced splenomegaly in myelofibrosis (MF) patients, with minimal impact on existing cytopenias providing an important therapeutic niche …See details»
ArrowBiome develops technology to kill specific bacteria in humans
1 day ago Most Read 1. HDB resale flat prices to grow slower in 2025 with constrained supply 2. Singapore to remain a top real estate investment prospect in Asia Pacific 2025 3. Rail system installation for Johor Bahru – Singapore link to begin by end-2024 4. Singapore told not to be …See details»